Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1461 results
Transgenomic announces issuance of new European patent covering COLD-PCR technologies
Transgenomic, a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, has announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies.
Automation > IT & Software > News
Theraclone enters into agreement with Gilead Sciences for broadly neutralizing HIV antibodies
Theraclone Sciences, a therapeutic antibody discovery and development company, announced today that it has entered into an agreement with Gilead Sciences under which Gilead received an exclusive license to develop and commercialize products incorporating Theraclone’s broadly neutralizing HIV-antibodies for therapeutic applications in HIV.
Automation > IT & Software > News
Cellectis sells Swedish subsidiary Cellectis to Takara Bio
Cellectis, a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART) has announced the sale of its subsidiary Cellectis AB to the Japanese Company Takara Bio.
Automation > IT & Software > News
EastGate expands pharmaceutical developments with sub-micron platform technology
EastGate Acquisitions, an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has announced expansion of its pharmaceutical development implementing its sub-micron platform technology.
Automation > IT & Software > News
Advaxis receives notice of allowance for cancer immunotherapies patent in Japan
Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has received a notice of allowance from the Japan Patent Office for a patent application related to the Advaxis proprietary Lm-LLO cancer immunotherapy platform technology
Automation > IT & Software > News
Lion, Moffitt Cancer Center partner to improve tumor infiltrating lymphocyte production
By PBR Staff Writer
Lion Biotechnologies that develops new cancer immunotherapies based on tumor infiltrating lymphocytes (TILs) has entered into an exclusive, worldwide license agreement with Moffitt Cancer Center.
Automation > IT & Software > News
biOasis releases quantitative results: siRNA-Transcendpep reduces target gene expression in the brain
BIOASIS TECHNOLOGIES, a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), has announced on May 6th, 2014, that its newly discovered carrier peptide-Transcendpep-effectively delivered siRNA across the BBB and into brain cells.
Automation > IT & Software > News
TransCelerate selects Cognizant to develop a clinical trials collaboration platform
Cognizant has announced that it has been selected by TransCelerate BioPharma, a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials.
Automation > IT & Software > News
MYOS gets notice of allowance of US Patent Application for manufacturing methods of Fortetropin
MYOS, an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, has recently received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application Serial No. 13/765,340 covering the Company's proprietary methods of manufacturing Fortetropin, the first clinically proven natural myostatin inhibitor.
Automation > IT & Software > News
Galena Biopharma inks licensing deal with MonoSol Rx for US rights of Zuplenz
By PBR Staff Writer
US-based biopharmaceutical firm Galena Biopharma has entered into a definitive agreement to license the US rights for Zuplenz (ondansetron) oral soluble film (OSF), from MonoSol Rx, the developer of the oral soluble film technology, PharmFilm, and manufacturer of the product.
Automation > IT & Software > News
Alnylam gets notice of allowance from USPTO for new patent broadly covering conjugate-based delivery of RNA Therapeutics
Alnylam Pharmaceuticals, a leading RNAi therapeutics company, has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the Manoharan et al. patent application 13/693,478.
Automation > IT & Software > News
Harvard Medical School, Phelan-McDermid Syndrome Foundation Contract leverages the tranSMART open-source knowledge management platform
The tranSMART Foundation has announced that the Phelan-McDermid Syndrome Foundation and the Center of Biomedical Informatics at Harvard Medical School were awarded a nearly $1 million contract from the Patient-Centered Outcomes Research Institute (PCORI) to undertake an exciting research endeavor that will leverage the tranSMART platform.
Automation > IT & Software > News
MorphoSys gets additional patents on Ylanthia in US and first patent in China
MorphoSys has announced that the US Patent and Trademark Office (USPTO) and the State Intellectual Property Office of China have granted additional patents covering the Company's latest antibody platform Ylanthia.
Automation > IT & Software > News
Agile Therapeutics announces allowance of additional patent claims for Skinfusion
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for additional patent claims covering dosing regimens using the Company's lead product candidate Twirla (ethinyl estradiol and levonorgestrel transdermal system (AG200-15)), currently in Phase 3 development.
Automation > IT & Software > News
Integral Molecular announces patent allowance for dengue research technology
Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs).
Automation > IT & Software > News
91-105 of 1461 results